Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001654954-17-009485
Filing Date
2017-10-17
Accepted
2017-10-16 20:38:44
Documents
10

Document Format Files

Seq Description Document Type Size
1 AMENDMENT NO. 2 ON FORM S-1 adg_s1a.htm S-1/A 2548461
2 SECOND AMENDMENT OF REGISTRATION RIGHTS AGREEMENT adg_ex48.htm EX-4.8 48823
3 EMPLOYMENT AGREEMENT, DATED OCTOBER 11, 2017, BETWEEN THE COMPANY AND JOHN LIATO adg_ex1028.htm EX-10.28 105801
4 WARRANT AGENT AGREEMENT, DATED AUGUST 14, 2017, BETWEEN THE COMPANY AND AEGIS CA adg_ex1034.htm EX-10.34 50243
5 EMPLOYMENT AGREEMENT, DATED SEPTEMBER 1, 2017, BETWEEN THE COMPANY AND FELIX GAR adg_ex1035.htm EX-10.35 95763
6 CONSENT OF MARCUM LLP adg_ex231.htm EX-23.1 3696
7 IMAGE adg_s1a000.jpg GRAPHIC 9297
8 IMAGE adg_s1a001.jpg GRAPHIC 16746
9 IMAGE adg_s1a002.jpg GRAPHIC 13318
10 IMAGE adg_s1a003.jpg GRAPHIC 27237
  Complete submission text file 0001654954-17-009485.txt   2946007
Mailing Address 4365 US 1 SOUTH, STE 211 PRINCETON NJ 08540
Business Address 4365 US 1 SOUTH, STE 211 PRINCETON NJ 08540 609-917-9784
Adgero Biopharmaceuticals Holdings, Inc. (Filer) CIK: 0001657598 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-216052 | Film No.: 171139704
SIC: 2834 Pharmaceutical Preparations